430 related articles for article (PubMed ID: 10069646)
61. Hyperhomocysteinemia in patients with stasis dermatitis and ulcer: a novel finding with important therapeutic implications.
Durmazlar SP; Akgul A; Eskioglu F
J Dermatolog Treat; 2009; 20(6):336-9. PubMed ID: 19954389
[TBL] [Abstract][Full Text] [Related]
62. Serum folate and homocysteine levels are associated with colon tumorigenesis in end-stage renal disease patients.
Kaji E; Kato J; Saito S; Harada K; Kuwaki K; Tatsukawa M; Morikawa T; Hiraoka S; Matsushima H; Yamamoto K
Nutr Cancer; 2011; 63(2):202-11. PubMed ID: 21264789
[TBL] [Abstract][Full Text] [Related]
63. Comparison of oral folic acid and folinic acid on blood homocysteine level of patients on hemodialysis.
Soleimani A; Usefzadeh M; Mianehsaz E; Foroozanfard F; Nikoueinejad H; Moraveji SA; Nasiri O; Rajali M
Iran J Kidney Dis; 2011 Jan; 5(1):45-9. PubMed ID: 21189434
[TBL] [Abstract][Full Text] [Related]
64. Hydroxocobalamin reduces hyperhomocysteinemia in end-stage renal disease.
Elian KM; Hoffer LJ
Metabolism; 2002 Jul; 51(7):881-6. PubMed ID: 12077735
[TBL] [Abstract][Full Text] [Related]
65. Folic acid supplementation inhibits NADPH oxidase-mediated superoxide anion production in the kidney.
Hwang SY; Siow YL; Au-Yeung KK; House J; O K
Am J Physiol Renal Physiol; 2011 Jan; 300(1):F189-98. PubMed ID: 20980407
[TBL] [Abstract][Full Text] [Related]
66. Homocysteine and C-reactive protein levels in haemodialysis patients.
Koulouridis E; Tzilianos M; Katsarou A; Costimba I; Klonou E; Panagiotaki E; Georgalidis C; Krokida A; Delaportas N; Lachanas A; Karaliotas G; Kaliolia I
Int Urol Nephrol; 2001; 33(2):207-15. PubMed ID: 12092633
[TBL] [Abstract][Full Text] [Related]
67. Homocysteine metabolism and effects of folic acid supplementation in patients affected with spina bifida.
Brouwer IA; van Dusseldorp M; Thomas CM; van der Put NM; Gaytant MA; Eskes TK; Hautvast JG; Steegers-Theunissen RP
Neuropediatrics; 2000 Dec; 31(6):298-302. PubMed ID: 11508548
[TBL] [Abstract][Full Text] [Related]
68. Effect of folic acid and betaine on fasting and postmethionine-loading plasma homocysteine and methionine levels in chronic haemodialysis patients.
van Guldener C; Janssen MJ; de Meer K; Donker AJ; Stehouwer CD
J Intern Med; 1999 Feb; 245(2):175-83. PubMed ID: 10081520
[TBL] [Abstract][Full Text] [Related]
69. [Is it necessary to supplement with folic acid patients in chronic dialysis treated with erythropoietin?].
Duclos J; Sieberth HG; Mann H
Rev Med Chil; 1993 Jan; 121(1):30-5. PubMed ID: 8235161
[TBL] [Abstract][Full Text] [Related]
70. Folic acid status of patients with chronic renal failure maintained by dialysis.
Hemmeloff Andersen KE
Clin Nephrol; 1977 Dec; 8(6):510-3. PubMed ID: 598056
[TBL] [Abstract][Full Text] [Related]
71. Effect of high dose folic acid therapy on hyperhomocysteinemia in hemodialysis patients: results of the Vienna multicenter study.
Sunder-Plassmann G; Födinger M; Buchmayer H; Papagiannopoulos M; Wojcik J; Kletzmayr J; Enzenberger B; Janata O; Winkelmayer WC; Paul G; Auinger M; Barnas U; Hörl WH
J Am Soc Nephrol; 2000 Jun; 11(6):1106-1116. PubMed ID: 10820175
[TBL] [Abstract][Full Text] [Related]
72. Therapy of hyperhomocysteinemia in hemodialysis patients: effects of folates and N-acetylcysteine.
Perna AF; Violetti E; Lanza D; Sepe I; Bellinghieri G; Savica V; Santoro D; Satta E; Cirillo G; Lupo A; Abaterusso C; Raiola I; Raiola P; Coppola S; Di Iorio B; Tirino G; Cirillo M; Ingrosso D; De Santo NG
J Ren Nutr; 2012 Sep; 22(5):507-514.e1. PubMed ID: 22226754
[TBL] [Abstract][Full Text] [Related]
73. Variations in the lipid profile of patients with chronic renal failure, treated with folic acid.
de Gómez Dumm NT; Giammona AM; Touceda LA
Int J Vitam Nutr Res; 2003 May; 73(3):215-20. PubMed ID: 12847999
[TBL] [Abstract][Full Text] [Related]
74. The effect of vitamin B6 and folate supplements on plasma homocysteine and serum lipids levels in patients on regular hemodialysis.
Ziakka S; Rammos G; Kountouris S; Doulgerakis C; Karakasis P; Kourvelou C; Papagalanis N
Int Urol Nephrol; 2001; 33(3):559-62. PubMed ID: 12230295
[TBL] [Abstract][Full Text] [Related]
75. Homocysteine lowering with folic acid supplements in children: effects on blood pressure.
Papandreou D; Malindretos P; Arvanitidou M; Makedou A; Rousso I
Int J Food Sci Nutr; 2010 Feb; 61(1):11-7. PubMed ID: 19939196
[TBL] [Abstract][Full Text] [Related]
76. Parenteral vitamin B12 reduces hyperhomocysteinemia in end-stage renal disease.
Kaplan LN; Mamer OA; Hoffer LJ
Clin Invest Med; 2001 Feb; 24(1):5-11. PubMed ID: 11266032
[TBL] [Abstract][Full Text] [Related]
77. Oral vitamin B(12) and high-dose folic acid in hemodialysis patients with hyper-homocyst(e)inemia.
Manns B; Hyndman E; Burgess E; Parsons H; Schaefer J; Snyder F; Scott-Douglas N
Kidney Int; 2001 Mar; 59(3):1103-9. PubMed ID: 11231366
[TBL] [Abstract][Full Text] [Related]
78. Hyperhomocysteinemia in chronic renal failure patients: relation to tissue factor and platelet aggregation.
Cetin O; Bekpinar S; Unlucerci Y; Turkmen A; Bayram C; Ulutin T
Clin Nephrol; 2006 Feb; 65(2):97-102. PubMed ID: 16509458
[TBL] [Abstract][Full Text] [Related]
79. Homocysteine-lowering therapy with folic acid is effective in cardiovascular disease prevention in patients with kidney disease: a meta-analysis of randomized controlled trials.
Qin X; Huo Y; Xie D; Hou F; Xu X; Wang X
Clin Nutr; 2013 Oct; 32(5):722-7. PubMed ID: 23313356
[TBL] [Abstract][Full Text] [Related]
80. A controlled trial of the effect of folate supplements on homocysteine, lipids and hemorheology in end-stage renal disease.
McGregor D; Shand B; Lynn K
Nephron; 2000 Jul; 85(3):215-20. PubMed ID: 10867536
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
